Morgan Stanley’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Morgan Stanley's BLSM Position: Q3 2026 in Review
Morgan Stanley opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 4,677 shares worth $87.2K. The stake represents ﹤0.01% of the portfolio and ranks #6371 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Morgan Stanley held 4,677 shares of BlossomHill Therapeutics worth $87.2K as of Q3 2026.
- BlossomHill Therapeutics was a new Morgan Stanley position in Q3 2026.
- BlossomHill Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6371 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.